Heartland Advisors Inc Harvard Bioscience Inc Transaction History

Heartland Advisors Inc

$1.87 Billion
Q1 2024

A detailed history of Heartland Advisors Inc transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Heartland Advisors Inc holds 889,133 shares of HBIO stock, worth $2.48 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

889,133

Previous 866,467 2.62%

Holding current value

$2.48 Million

Previous $4.64 Million 18.68%

% of portfolio

0.2%

Previous 0.25%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$4.02 - $5.39 $91,117 - $122,169	22,666 Added 2.62%	889,133 $3.77 Million
Q3 2023 Nov 08, 2023	BUY	$4.0 - $5.82 $65,868 - $95,837	16,467 Added 1.94%	866,467 $3.73 Million
Q2 2023 Aug 10, 2023	SELL	$4.19 - $6.16 $1.47 Million - $2.16 Million	-350,000 Reduced 29.17%	850,000 $4.67 Million
Q1 2023 May 11, 2023	BUY	$2.45 - $4.22 $209,722 - $361,236	85,601 Added 7.68%	1,200,000 $5.04 Million
Q4 2022 Feb 08, 2023	BUY	$2.12 - $2.86 $136,525 - $184,181	64,399 Added 6.13%	1,114,399 $3.09 Million

Q3 2022 Nov 10, 2022	BUY	$2.58 - $3.92 $1.08 Million - $1.64 Million	418,410 Added 66.25%	1,050,000 $2.69 Million
Q2 2022 Aug 12, 2022	BUY	$3.28 - $6.42 $759,615 - $1.49 Million	231,590 Added 57.9%	631,590 $2.27 Million
Q3 2021 Nov 09, 2021	SELL	$6.98 - $8.47 $2.44 Million - $2.96 Million	-350,000 Reduced 46.67%	400,000 $2.79 Million
Q2 2021 Aug 11, 2021	SELL	$5.44 - $8.4 $1.09 Million - $1.68 Million	-200,000 Reduced 21.05%	750,000 $6.25 Million
Q1 2021 May 12, 2021	SELL	$3.91 - $6.99 $44,574 - $79,686	-11,400 Reduced 1.19%	950,000 $5.19 Million
Q3 2020 Nov 12, 2020	SELL	$2.75 - $4.2 $106,150 - $162,120	-38,600 Reduced 3.86%	961,400 $2.89 Million
Q1 2019 May 13, 2019	SELL	$2.77 - $4.38 $298,542 - $472,063	-107,777 Reduced 9.73%	1,000,000 $4.31 Million
Q3 2018 Nov 08, 2018	SELL	$5.0 - $6.65 $1.43 Million - $1.91 Million	-286,651 Reduced 20.56%	1,107,777 $5.82 Million
Q2 2018 Aug 02, 2018	SELL	$4.2 - $5.95 $666,002 - $943,503	-158,572 Reduced 10.21%	1,394,428 $7.46 Million
Q1 2018 May 10, 2018	SELL	$3.3 - $5.15 $472,645 - $737,613	-143,226 Reduced 8.44%	1,553,000 $7.77 Million
Q4 2017 Feb 02, 2018	SELL	$3.08 - $3.8 $935,623 - $1.15 Million	-303,774 Reduced 15.19%	1,696,226 $5.6 Million
Q3 2017 Oct 25, 2017	BUY	$2.7 - $3.75 $5.4 Million - $7.5 Million	2,000,000	2,000,000 $7.5 Million

Others Institutions Holding HBIO

# of Institutions

Shares Held

32.8M

Call Options Held

Put Options Held

2.2K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $116M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Heartland Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Heartland Advisors Inc with notifications on news.

Account

Heartland Advisors Inc Harvard Bioscience Inc Transaction History